Report copyright - Presentación de PowerPoint · • Regulators prefer OS vs. surrogate endpoints, especially in an aggressive and fatal disease such as SCLC • Greater chance of approval and uptake
Please pass captcha verification before submit form
Please pass captcha verification before submit form